pennsylvania biotechnology center photobanner
 
check
pattern

Seminar Series Schedule 2012

An annual Seminar Series is co-sponsored by the Baruch S. Blumberg Institute, the Hepatitis B Foundation, and the Drexel Institute to promote scientific exchange at the national and international level.

12/13/12 – James Hendrix, PhD (nPharmakon)
“Antipsychotics or Just Psychotic - Adventures in CNS Drug Discovery”

12/6/12 – Robert Lanford, PhD (Texas Biomedical Research Institute)
“The Chimpanzee Model of HCV and HBV Infections; Novel Therapeutics Based on microRNAs and Toll-Like Receptors”

11/27/12 – John J. Baldwin, PhD  (Cleo Pharmaceuticals)
“The Decline in Industrial Drug Discovery and the Rise in Mergers, Alliances and Outsourcing”
PDDI’s 2012 Drug Discovery Award Recipient

11/15/12 – Arnold Levine, PhD (Institute for Advanced Study)
“Influenza, Epidmiology and Genomics”

11/8/12 – Rodrigo Andrade, PhD  (Temple University)
“Adventures in Chemical Synthesis – Part: I: Discovery of Novel Macrolide Antibiotics, Part II: Total Synthesis of Strychnos Alkaloids”

10/25/12 – Michael Bray, MD, MPH (NIAID/NIH)
“Current Research Questions in Viral Hemorrhagic Fever”

10/18/12 – Patrick Loll, PhD (Drexel University College of Medicine)
“Killing bad guys with X-rays: How structure can inform antibiotic design”

10/12/12 – Annual Biotech Conference* (Regional Biotech Council)
"Biotech Success Stories of the Region" An Industry with Renewed Opportunity

10/11/12 – Jesus Prieto, PhD (DIGNA Biotech)
“DIGNA-CIMA hepatology program: From hepatitis to liver fibrosis and cancer”

8/30/12 – Michael Racke, MD (Wexner Medical Center at The Ohio State University)
“Will small RNA lead to big results in multiple sclerosis?”

8/17/12 – T. Rajendra Kumar, PhD (University of Kansas Medical Center)
“Genetics and pathophysiology of pituitary null cell tumors” 

8/14/12 – Pauline Rudd, PhD (University College Dublin)
“Glycobiology: The importance of glycosylation from the bench to the clinic”

8/7/12 - Massimo Levrero, MD (Sapienza University – Rome)
“Investigating cccDNA function: Implications for the cure of HBV infection”

8/2/12 – Lisa Minor (In Vitro Strategies, LLC)
“Reproducible and Quantitative Analysis of Cell Morphology and Subcellular Structures Through Controlling Cell Surface Adhesion-2D+” 

7/31/12 - Michael Poisel & Heather Steinman, PhD* (UPStart, University of Pennsylvania)
“UPstart: Incubating Innovation” 

 7/26/12 - Zhaoyu Li, PhD (University of Pennsylvania School of Medicine)
“Foxa in liver development and cancer”

 7/19/12 – Anthony Ford-Hutchinson, PhD (Former Sr. VP, Merck Research Laboratories)
"Challenges in the Discovery and Distribution of Novel Vaccines"

 7/12/12 - Mauricio Reginato, Ph.D. (Drexel University College of Medicine)
“Targeting O-GlcNacylation: Taking the sugar out of cancer”

7/10/12 – Jose Falconi* (VerdanTech LLC)
“Why Look to Latin America for Potential Business, and What’s Essential to Know? (Brazil as Case Study)”

6/28/12 – Michael Nonnemacher, PhD (Drexel University College of Medicine)
“HIV-1 LTR polymorphisms as potential markers for peripheral and neurologic disease progression”

06/08/12 - Snorri S.Thorgeirsson, MD, PhD (Center for Cancer Research, Nat. Cancer Inst., NIH)
“Deconstructing Liver Cancer: From Genome to Stem cells”
Hepatitis B Foundation’s 2012 Bruce Witte Lecturer

5/24/12 – Hydar Ali, PhD (University of Pennsylvania)
“Human mast cells and humanized mice for the study of host defense and allergic asthma”

5/17/12 – George Trainor, PhD  (Trainor Consulting, LLC)
“Chemical principles of drug action in vivo”

4/27/12 – Howard K. Koh, MD, MPH (US Dept. of Health & Human Services)
A National Strategy for the Prevention and Control of Viral Hepatitis”
Hepatitis B Foundation’s 2012 Baruch S. Blumberg Prize

4/26/12 – Scott L. Diamond, PhD  (Inst. of Medicine & Engineering, University of Pennsylvania)
"High Throughput Biotechnology"

4/05/12 – Patrick Lam, PhD  (Lam Drug Discovery Consulting, LLC)
“Structure-based Discovery of the Factor Xa Inhibitor, Eliquis® (Apixaban), as a Novel Anticoagulant”

3/29/12 – Joseph Aceto, PhD, Esq.*  (Aceto Intellectual Property Law)
"A Legal Primer for Scientists, Entrepreneurs, and Biotech Companies"

3/15/12 – Todd Schell, PhD (Pennsylvania State University College of Medicine)
“Targeting the Strong and the Weak:  Recruiting CD8+ T Cells Against SV40 Large T Antigen”

2/16/12 – Frederic Bushman, PhD (University of Pennsylvania School of Medicine)
“The Human Microbiome in Health and Disease”

2/2/12 – Robert Doms, MD, PhD (University of Pennsylvania School of Medicine)
“Reconstructing Berlin: Zinc-finger nucleases and HIV-1 therapy”

 

*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)

**Pennyslvania Drug Discovery Institute Seminar Speakers

 

Past Seminar Series

2011

2010

2009

2008

Hepatitis B Foundation
delaware college